These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18339647)

  • 21. Volume overload induces differential spatiotemporal regulation of myocardial soluble guanylyl cyclase in eccentric hypertrophy and heart failure.
    Liu Y; Dillon AR; Tillson M; Makarewich C; Nguyen V; Dell'Italia L; Sabri AK; Rizzo V; Tsai EJ
    J Mol Cell Cardiol; 2013 Jul; 60():72-83. PubMed ID: 23567617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effect of the soluble guanylyl cyclase stimulator BAY 41-2272 on impaired penile erection in db/db-/- type II diabetic and obese mice.
    Nunes KP; Teixeira CE; Priviero FB; Toque HA; Webb RC
    J Pharmacol Exp Ther; 2015 May; 353(2):330-9. PubMed ID: 25740897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.
    Hussain MB; Hobbs AJ; MacAllister RJ
    Br J Pharmacol; 1999 Nov; 128(5):1082-8. PubMed ID: 10556946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide sensitive-guanylyl cyclase subunit expression changes during estrous cycle in anterior pituitary glands.
    Cabilla JP; Ronchetti SA; Nudler SI; Miler EA; Quinteros FA; Duvilanski BH
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E731-7. PubMed ID: 19141686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
    Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. sGC(alpha)1(beta)1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models.
    Buys ES; Cauwels A; Raher MJ; Passeri JJ; Hobai I; Cawley SM; Rauwerdink KM; Thibault H; Sips PY; Thoonen R; Scherrer-Crosbie M; Ichinose F; Brouckaert P; Bloch KD
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H654-63. PubMed ID: 19502556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment.
    Ahluwalia A; Foster P; Scotland RS; McLean PG; Mathur A; Perretti M; Moncada S; Hobbs AJ
    Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1386-91. PubMed ID: 14742866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted genomic disruption of h-ras induces hypotension through a NO-cGMP-PKG pathway-dependent mechanism.
    Chamorro-Jorganes A; Grande MT; Herranz B; Jerkic M; Griera M; Gonzalez-Nuñez M; Santos E; Rodriguez-Puyol D; Lopez-Novoa JM; Rodriguez-Puyol M
    Hypertension; 2010 Sep; 56(3):484-9. PubMed ID: 20679183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models.
    Sharkovska Y; Kalk P; Lawrenz B; Godes M; Hoffmann LS; Wellkisch K; Geschka S; Relle K; Hocher B; Stasch JP
    J Hypertens; 2010 Aug; 28(8):1666-75. PubMed ID: 20613628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the JNK inhibitor anthra[1,9-cd]pyrazol-6(2H)-one (SP-600125) on soluble guanylyl cyclase alpha1 gene regulation and cGMP synthesis.
    Krumenacker JS; Kots A; Murad F
    Am J Physiol Cell Physiol; 2005 Oct; 289(4):C778-84. PubMed ID: 15888553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The alpha1 isoform of soluble guanylate cyclase regulates cardiac contractility but is not required for ischemic preconditioning.
    Sips PY; Brouckaert P; Ichinose F
    Basic Res Cardiol; 2011 Jun; 106(4):635-43. PubMed ID: 21394564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble guanylate cyclase modulators blunt hyperoxia effects on calcium responses of developing human airway smooth muscle.
    Britt RD; Thompson MA; Kuipers I; Stewart A; Vogel ER; Thu J; Martin RJ; Pabelick CM; Prakash YS
    Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(6):L537-42. PubMed ID: 26254425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interstitial cells of Cajal contain signalling molecules for transduction of nitrergic stimulation in guinea pig caecum.
    Iino S; Horiguchi K; Nojyo Y; Ward SM; Sanders KM
    Neurogastroenterol Motil; 2009 May; 21(5):542-50, e12-3. PubMed ID: 19175750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
    Evgenov OV; Kohane DS; Bloch KD; Stasch JP; Volpato GP; Bellas E; Evgenov NV; Buys ES; Gnoth MJ; Graveline AR; Liu R; Hess DR; Langer R; Zapol WM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1138-45. PubMed ID: 17872487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney.
    Bai Y; Ye S; Mortazavi R; Campese V; Vaziri ND
    Am J Physiol Renal Physiol; 2007 Mar; 292(3):F974-80. PubMed ID: 17122386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble guanylyl cyclase α1 and p53 cytoplasmic sequestration and down-regulation in prostate cancer.
    Cai C; Hsieh CL; Gao S; Kannan A; Bhansali M; Govardhan K; Dutta R; Shemshedini L
    Mol Endocrinol; 2012 Feb; 26(2):292-307. PubMed ID: 22174378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of soluble guanylyl cyclase by BAY 41-2272 relaxes anococcygeus muscle: interaction with nitric oxide.
    Teixeira CE; Priviero FB; Claudino MA; Baracat JS; De Nucci G; Webb RC; Antunes E
    Eur J Pharmacol; 2006 Jan; 530(1-2):157-65. PubMed ID: 16371226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy.
    Trappanese DM; Liu Y; McCormick RC; Cannavo A; Nanayakkara G; Baskharoun MM; Jarrett H; Woitek FJ; Tillson DM; Dillon AR; Recchia FA; Balligand JL; Houser SR; Koch WJ; Dell'Italia LJ; Tsai EJ
    Basic Res Cardiol; 2015 Jan; 110(1):456. PubMed ID: 25480109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small intestinal motility in soluble guanylate cyclase alpha1 knockout mice: (Jejunal phenotyping of sGCalpha1 knockout mice).
    Dhaese I; Vanneste G; Sips P; Buys ES; Brouckaert P; Lefebvre RA
    Naunyn Schmiedebergs Arch Pharmacol; 2009 May; 379(5):473-87. PubMed ID: 19052725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of phosphodiesterase type 5 by the activator of nitric oxide-sensitive guanylyl cyclase BAY 41-2272.
    Mullershausen F; Russwurm M; Friebe A; Koesling D
    Circulation; 2004 Apr; 109(14):1711-3. PubMed ID: 15066950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.